首页> 外文期刊>Revista da Sociedade Brasileira de Medicina Tropical >Clinical, laboratory, and therapeutic characteristics of American tegumentary leishmaniasis in the 15 th State Health Division, Northwest Paran?? State, Southern Brazil
【24h】

Clinical, laboratory, and therapeutic characteristics of American tegumentary leishmaniasis in the 15 th State Health Division, Northwest Paran?? State, Southern Brazil

机译:美国西北帕拉恩州第15州卫生局的美国皮肤性利什曼病患者的临床,实验室和治疗特征?巴西南部州

获取原文
           

摘要

INTRODUCTION American tegumentary leishmaniasis (ATL) is an endemic disease in many regions of Brazil; however, only few reports on the actual epidemiological conditions are available. Here, we aimed to assess the clinical, epidemiological, and laboratory characteristics of ATL patients and their treatment in the 15 th Regional Health Division of Paran?? State, Maring??, Brazil. METHODS This epidemiological study included patients diagnosed with ATL from January 2010 to September 2014, from the 15 th Regional Health Division database. RESULTS A total of 220 cases aged 3-84 years (85% male and 60.9% with up to 8 years of schooling) were included. The cases were classified as having the cutaneous form (n=183; 83.2%), mucosal form (n=26; 11.8%), mucocutaneous form (n=11; 5%), and relapses (n=21; 9.6%). Diagnosis was made via laboratory test results in 197 (89.5%) patients, and 172 (78.2%) completed the treatment within the study period. With regard to patients with the cutaneous form, 134 (95%) were cured, 131 (97.8%) were treated with Glucantime(r), and 47 (36.7%) received dosage of >15 and <20mg Sb 5+ /kg/day. Among the cases with mucosal involvement, 87.1% were cured and most were treated with <20mg Sb 5+ /kg/day. Thus, the cure rate was 93.6%. CONCLUSIONS During the study period in the 15 th Regional Health Division of Paran?? State, ATL cases had a good response to treatment with a low rate of relapse or treatment failure, although a high percentage of mucosal or mucocutaneous form cases was also noted.
机译:引言美国皮肤性利什曼病(ATL)是巴西许多地区的地方病;然而,关于实际流行病学状况的报道很少。在这里,我们旨在评估ATL患者的临床,流行病学和实验室特征及其在Paran的第15区域卫生部门的治疗方法。巴西马林州。方法这项流行病学研究纳入了2010年1月至2014年9月从第15个地区卫生部数据库中诊断出患有ATL的患者。结果共纳入220例年龄在3-84岁之间的病例(其中85%的男性为80.9%,男性为60.9%)。这些病例被分类为具有皮肤形式(n = 183; 83.2%),粘膜形式(n = 26; 11.8%),皮肤粘膜形式(n = 11; 5%)和复发(n = 21; 9.6%) 。通过实验室测试结果对197位患者(89.5%)进行了诊断,并且有172位患者(78.2%)在研究期内完成了治疗。皮肤病患者治愈134(95%),131(97.8%)接受Glucantime(r)治疗,47(36.7%)接受的剂量大于15和小于20mg Sb 5+ / kg /天。在粘膜受累的病例中,治愈的占87.1%,大多数接受了<20mg Sb 5+ / kg / day的治疗。因此,治愈率为93.6%。结论在研究期间,在波兰的第15区域卫生部门?州,ATL病例对治疗的反应良好,复发率或治疗失败率低,尽管也注意到高比例的粘膜或粘膜皮肤病例。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号